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  EVIDENCE-BASED ANSWER 
There is insufficient evidence to recommend for or against an EST for screening asymptomatic individuals of 
any age. (Grade of Recommendation: C, based on case series.) 
  EVIDENCE SUMMARY 
Several case series have demonstrated that occult coronary heart disease (CHD) can be identified by screening 
asymptomatic adults with an EST, some of whom will ultimately experience CHD death. The best estimates of 
sensitivity and specificity of the EST for identifying occult CHD are 45% and 85%, respectively.1 The sensitivity 
for detection of risk for cardiac death is lower; sensitivities between 27%2 and 61%3 have been reported. In a 
population with a low risk of CHD death, the positive predictive value (percent with a positive test who actually 
have CHD) will be low. 
Patients and clinicians might be more likely to address risk factors for cardiovascular disease in patients with 
silent ischemia. However, it has never been shown that early intervention of known ischemia during its 
asymptomatic phase improves CHD outcome. 
Limiting screening to those at high risk for CHD would improve the predictive value of a positive test. One 
study5 of middle-aged asymptomatic men and recorded the presence of a first-degree relative with heart 
disease, systolic blood pressure of 140 mm Hg or greater, smoking, or total cholesterol higher than 250 mg per 
dL. Men with any of these risk factors had significantly higher CHD event incidence if they had 2 or more EST 
abnormalities than those with less than 2 EST abnormalities. The authors concluded that routine screening of 
asymptomatic men without these risk factors was not warranted, but the uncertain efficacy of earlier intervention 
remains. 
Screening individuals in occupations that can affect public safety, such as airline pilots, would identify some 
individuals at risk for sudden cardiac death, though the population impact of this would be miniscule. Screening 
individuals who will be engaging in strenuous physical activity would also be effective at detecting at least some 
people who are at risk of sudden death. However, only 2% of cardiac deaths occur during exercise,2 and it 
again is not clear that early intervention improves outcome. 
  RECOMMENDATIONS FROM OTHERS 
The United States Preventive Services Task Force found insufficient evidence to recommend for or against the 
use of screening EST in middle-aged individuals.2 The American Heart Association and the American College 
of Cardiology advise against routine screening of asymptomatic men or women but suggested that there might 
be value in screening individuals who plan to start a vigorous exercise program, who are involved in 
occupations in which impairment might have an impact on public safety, or who are at high risk for CHD due to 
other diseases.6 The American College of Sports Medicine, in a joint opinion with the American Heart 
Association, recommends a screening EST for men older than of 45 years who are about to embark on a 
vigorous exercise program.7 
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The studies that came to a mixed conclusion looked at the test strictly as a diagnostic tool 
to detect ischemic coronary artery disease. Widespread use of the test persists for other 
reasons; studies have associated excellent prognosis with negative test results and higher 
mortality risk with lower fitness levels. Information such as this leads me to use the test for 
patients wishing to pursue vigorous exercise or for those with cardiac risk factors, 
regardless of symptoms. 
R E F E R E N C E S  
1. Froelicher  VF, Lehmann  KG, Thomas  R , et al.   Ann Intern Med 1998;128:965–74. 
2. US Preventive Services Task Force.  Guide to clinical preventive services:report of 
the US Preventive Services Task Force. 2nd ed. Baltimore, Md:Williams and Wilkins; 
1996:3-14. 
3. Gibbons  LW, Mitchell  TL, Wei  M, Blair  SN, Cooper  KH.  Am J 
Cardiol 2000;86:53–58. 
4. Bruce  RA, Hossack  KF, DeRouen  TA, Hofer  V.  J Am Coll Cardiol 1983;2:565–73. 
5. Gibbons  RJ, Balady  GJ, Beasley  JW , et al.   Circulation 1997;96:345–54. 
6. Balady  GJ, Chaitman  B, Driscoll  D , et al.   Circulation 1998;97:2283–93. 
 
